Orchid Pharma Share Price (ORCHPHARMA)
Check the latest share price of Orchid Pharma, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 06 Jun 2025
NSE
Orchid Pharma Stock Performance
Get live Orchid Pharma share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹709.3Day's Price Range₹733.4552 Week's Low
52 Week's High
₹603.852-Week Price Range₹1,997.4
| Returns % | |
| 1 Month Return | -10.62 % |
| 3 Month Return | -25.73 % |
| 1 Year Return | -33.03 % |
| 3 Year Return | + 142.37 % |
| 5 Year Return | + 3889.72 % |
| Market Stats | |
| Previous Close | ₹723.00 |
| Open | ₹724.50 |
| Volume | 1.50L |
| Upper Circuit | ₹759.15 |
| Lower Circuit | ₹686.85 |
Orchid Pharma Fundamentals & Key Indicators
Check Orchid Pharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹3,642.39 Cr
Return on Equity (ROE)
3.15
PE Ratio (TTM)
36.53
Return on capital employed (ROCE)
3.33
Industry PE ratio
56.05
Beta (LTM)
1
P/B Ratio
4.61
Dividend Yield
0PEG Ratio
70.25
Quarterly Earnings Growth YOY
-42.9
EPS (TTM)
18.74
Sector
Pharmaceuticals
Book Value
217.06
Technical Analysis
Bearish
View Technical Analysis
How to invest in Orchid Pharma?
Investing in Orchid Pharma is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Orchid Pharma or ORCHPHARMA on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Orchid Pharma or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Orchid Pharma with just a few clicks!
Orchid Pharma Stock's Interest Amongst Investors
Orchid Pharma Valuation
Track how Orchid Pharma P/E has moved over time to understand its valuation trends.
Orchid Pharma in the last 5 years
Lowest (-871.56x)
April 8, 2022
Today (36.53x)
June 6, 2025
Industry (56.05x)
June 6, 2025
Highest (105.04x)
September 14, 2022
Today’s Price to Earnings Ratio: 36.53x
Orchid Pharma Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Orchid Pharma.
based on 3 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
100% of analysts recommend a 'BUY' rating for Orchid Pharma. Average target price of ₹1000.67
Source: S&P Global Market Intelligence
Orchid Pharma Share Price Target
Get share price movements and forecasts by analysts on Orchid Pharma.
Orchid Pharma price forecast by 3 analysts
Upside of39.34%
High
₹1112
Target
₹1000.67
Low
₹900
Orchid Pharma target price ₹1000.67, a slight upside of 39.34% compared to current price of ₹718.15. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Orchid Pharma revenue growth forecast
Expected growth rate Q1, FY2027:101.80%
Forecast
Actual
Including amortisation and stock based compensations
Orchid Pharma EPS growth forecast
EPS estimate Q1, FY2027:84.20%
Forecast
Actual
Source: S&P Global Market Intelligence
Orchid Pharma Financial Results
Get the annual and quarterly financial summary of Orchid Pharma, including revenue, profit, loss and more.
Indices Featuring Orchid Pharma Stock
Check stock indices that include Orchid Pharma.
Orchid Pharma Earnings and Dividends
View detailed summary of the earnings and dividend history of Orchid Pharma.
Orchid Pharma Ltd Earnings Results
Orchid Pharma Ltd’s net profit fell -32.37% since last year same period to ₹22.29Cr in the Q4 2024-2025. On a quarterly growth basis, Orchid Pharma Ltd has generated 7.27% jump in its net profits since last 3-months.
Read More about Earnings Results
Orchid Pharma Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Orchid Pharma.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 69.84% | 0.00 | |
| Foreign Institutions | 2.69% | 0.00 | |
| Mutual Funds | 18.79% | 0.00 | |
| Retail Investors | 7.38% | 0.00 | |
| Others | 1.31% | 0.00 |
Orchid Pharma vs Peers
Compare market cap, revenue, PE, and other key metrics of Orchid Pharma with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 3,642.39 | 777.94% | 0.55 | NA | NA | |
| NA | 795.42 | 167.43% | 0.62 | NA | NA | |
| NA | 2,771.43 | 113.72% | 0.56 | NA | NA | |
| NA | 112.55 | 48.04% | 0.51 | NA | NA | |
| BUY | 19,412.57 | 3.69% | 0.55 | NA | NA |
Orchid Pharma News & Key Events
Latest news and events in one place to help you make informed investing decisions in Orchid Pharma.
Orchid Pharma Reports Profit Decline, Shares Fall - 27 May, 2025
Orchid Pharma's Q4 net profit fell 32.4% YoY to Rs 22.3 crore, despite a 9.4% rise in revenue. Shares dropped nearly 5% following the announcement.
Insights on Orchid Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, ORCHPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 2.53% to 2.69% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 20.78 Cr → 22.29 Cr (in ₹), with an average increase of 6.8% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 17.46% to 18.79% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 225.83 Cr → 241.38 Cr (in ₹), with an average increase of 6.4% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, ORCHPHARMA stock has moved up by 8.8%
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 44.7% return, outperforming this stock by 77.7%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 69.84% of holdings in Mar 2025 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 8.64% to 7.38% in Mar 2025 quarter
About Orchid Pharma
Revenue: ₹237.48Cr as on March 2025 (Q4 FY25)
Net Profit: ₹19.13Cr as on March 2025 (Q4 FY25)
Listing date: 12 May, 1995
Chairperson Name: Ram Gopal Agarwal
| Organisation | Orchid Pharma Ltd |
| Industry | Pharmaceuticals |
| CEO | Ram Gopal Agarwal |
| E-voting on shares | Click here to vote |
Mutual Funds that own Orchid Pharma
Check out the Mutual Funds with significant holdings in Orchid Pharma.
FAQs
What is Orchid Pharma share price today?
Orchid Pharma share price today stands at ₹718.15, Open: ₹724.5, Previous Close: ₹723, High: ₹733.45, Low: ₹709.3, 52 Week High: ₹1997.4, 52 Week Low: ₹603.8.
What is today's traded volume of Orchid Pharma?
Today's traded volume of Orchid Pharma is 1.50L. Which means that 1.50L shares of Orchid Pharma were bought and sold on the stock market during today's trading session.
What is Orchid Pharma's market cap today?
Today's market capitalisation of Orchid Pharma is ₹3,642.39 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Orchid Pharma?
Orchid Pharma’s 52 week high is ₹1997.4 and 52 week low is ₹603.8. The current share price of Orchid Pharma is ₹718.15, which is -64.05% down from its 52 week high and 18.94% up from its 52 week low.